封面
市場調查報告書
商品編碼
1892124

家庭醫療保健領域的創新與成長機遇

Healthcare at Home Innovation and Growth Opportunities

出版日期: | 出版商: Frost & Sullivan | 英文 57 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

在家即可享受個人化、便利的醫院級疾病管理服務

受門診服務以及居家監測、治療和復健需求成長的推動,居家醫療已成為現代醫學領域發展最快的領域之一。診所和醫院患者數量的不斷增加促使聯邦政府推出主導,以促進採用創新解決方案,實現分散式醫療服務。新冠疫情加速了這一趨勢,監管機構已授予市售遠端監測設備和數位療法緊急使用授權,使這些技術能夠在主流醫療保健中發揮合法作用。

居家醫療技術涵蓋技術創新、易用性和成本效益,使其成為研究人員和行業相關人員關注的重點分析領域。本研究探討了重塑傳統醫療保健服務模式的新興全球趨勢,重點是數位療法、穿戴式裝置和智慧型手機監測平台。研究尤其關注心血管疾病和精神疾病管理領域的應用,這些領域在居家醫療環境中正迅速普及。本研究不僅評估了這些創新的優勢和技術成熟度,也確定了未來五年可能塑造競爭格局的關鍵企業和技術開發人員。

目錄

家庭醫療保健領域的創新與成長機會

  • 策略要務
  • 為什麼成長變得越來越困難
  • The Strategic Imperative 8
  • 三大策略要務對居家醫療產業的影響
  • 成長引擎由成長機會驅動
  • 調查方法

成長機會分析

  • 分析範圍
  • 居家醫療PPP 價值三要素 - 病人真的能在醫院復健嗎?
  • 居家醫療的具體影響和益處
  • 居家醫療服務模式
  • 推動居家醫療產業轉型發展的關鍵演進趨勢
  • 美國食品藥物管理局(FDA)居家醫療指南的主要要點
  • FDA已通過核准的家用醫療設備(510k)
  • 市場區隔

成長泉

  • 成長要素
  • 成長抑制因素

技術概述

  • 去心房顫動- 概述
  • 2020年至2025年間擁有臨床核准的AED和WCD的公司
  • 血壓計概述
  • 企業應採取行動 - 2020年至2025年間獲得臨床核准的血壓監測儀

技術概述

  • 精神健康數位化治療作為醫療設備軟體(SaMD) - 概述
  • 企業應採取行動 - 2020年至2025年臨床核准的精神健康直接治療藥物
  • 未來技術藍圖

相關人員生態系統

  • 臨床試驗資料庫分析
  • 居家醫療創新專利申請分析(2021-2025)
  • 美國聯邦資金分析
  • 私人資金籌措分析
  • 併購趨勢(2023-2024)

成長機會領域

  • 成長機會1:聚焦兩個尚未開發的市場:印度市場與藥物濫用問題
  • 成長機會2:家庭醫療設備技術開發商與護理即服務(CaaS)提供者之間的合作
  • 成長機會3:優先考慮女性作為最終使用者和護理協調員的技術開發人員

附錄

  • 技術成熟度等級(TRL)解釋

未來計劃

  • 成長機會帶來的益處和影響
  • 下一步
  • 免責聲明
簡介目錄
Product Code: DB4A

Personalized and Accessible Hospital-Grade Disease Management at Home

Healthcare at home is emerging as one of the fastest-growing fields in modern medicine, driven by the rising demand for outpatient services, home-based monitoring, treatment, and rehabilitation. Increasing patient loads in clinics and hospitals have spurred federal initiatives that encourage the adoption of innovative solutions for decentralized care delivery. The pandemic accelerated this momentum, during which regulatory authorities granted emergency use authorization for over-the-counter remote monitoring devices and digital therapeutics, legitimizing their role in mainstream healthcare.

The scope of healthcare at home technologies spans technical innovation, user-friendliness, and cost-effectiveness, making them a critical area of analysis for researchers and industry stakeholders. This study explores emerging global trends reshaping conventional healthcare delivery models, focusing on digital therapeutics, wearable devices, and smartphone-enabled monitoring platforms. Special attention is given to their applications in managing cardiovascular diseases and mental health conditions, which are witnessing rapid uptake in home-care settings. In addition to assessing these innovations' advantages and technology readiness levels, the study identifies leading incumbents and technology developers poised to shape the competitive landscape over the next 5 years.

Table of Contents

Healthcare at Home Innovations & Growth Opportunities

  • Strategic Imperatives
  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8
  • The Impact of the Top 3 Strategic Imperatives on the Healthcare at Home Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • PPP Value Triad of Healthcare at Home-Do Patients Really Heal in Hospitals?
  • Elaborate Implications and Benefits of Healthcare at Home
  • Healthcare at Home Care Delivery Model
  • Key Evolving Trends Leading to Industry Shifts in Healthcare at Home
  • Key Takeaways from the US Food & Drug Administration FDA Guidelines for Healthcare at Home
  • 510k FDA-Approved Home-Use Medical Devices
  • Segmentation

Growth Generator

  • Growth Drivers
  • Growth Restraints

Technology Snapshot

  • Defibrillators-Overview
  • Companies to Action-AEDs and WCDs Clinically Cleared between 2020 and 2025
  • BP Monitors-Overview
  • Companies to Action-Clinically Cleared BP Monitors between 2020 and 2025

Technology Snapshot

  • Mental Health DTx as Software as a Medical Device SaMD-Overview
  • Companies to Action-Clinically Approved Mental Health DTx between 2020 and 2025
  • Future Technology Roadmap

Stakeholder Ecosystem

  • Clinical Trials Database Analytics
  • Filed Patent Analysis for Healthcare at Home Innovations, 2021-2025
  • Federal Funding Analysis in the United States
  • Private Funding Analysis
  • Mergers and Acquisitions, 2023-2024

Growth Opportunity Universe

  • Growth Opportunity 1: Targeting 2 Untapped Markets: India and Substance Overuse
  • Growth Opportunity 2: Partnerships between Technology Developers of Home-Use Medical Devices and Care-as-a-Service CaaS Providers
  • Growth Opportunity 3: Technology Developers Prioritizing Women as End Users and Care Coordinators

Appendix

  • Technology Readiness Levels TRL: Explanation

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer